Travere director sells shares after option exercise
Travere Therapeutics, Inc. director Roy D. Baynes carried out an exercise-and-sell transaction involving company stock.
Rhea-AI Filing Summary
Travere Therapeutics, Inc. director Roy D. Baynes carried out an exercise-and-sell transaction involving company stock. On May 1, 2026, he exercised stock options to acquire 9,750 shares of common stock at $6.82 per share, then sold 9,750 shares in an open-market transaction at $44.22 per share.
The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on November 17, 2025, indicating it was scheduled in advance. Following these transactions, Baynes directly holds 37,500 shares of Travere common stock, and the exercised option is now fully vested and exercisable with no remaining derivative position from that specific grant.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,750 shares ($365K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Baynes Roy D.
Role
Director
Sold
9,750 shs ($431K)
Approx. gross sale proceeds
$431K
Approx. exercise cost
$66K
Approx. pre-tax spread
$365K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock option (right to buy) | 9,750 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,750 | $6.82 | $66K |
| Sale | Common Stock | 9,750 | $44.22 | $431K |
Holdings After Transaction:
Stock option (right to buy) — 9,750 contracts (Direct);
Common Stock — 37,500 shares (Direct)
Footnotes (2)
- F1. This sale was made pursuant to a written plan adopted on November 17, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying stock options granted to the Reporting Person.
- F2. The stock option is fully vested and exercisable.
Key Figures
Shares sold: 9,750 shares
Sale price: $44.22 per share
Options exercised: 9,750 shares
+3 more
6 metrics
Shares sold
9,750 shares
Common stock sold in open market on May 1, 2026
Sale price
$44.22 per share
Price for 9,750 Travere common shares sold
Options exercised
9,750 shares
Common shares acquired via option exercise on May 1, 2026
Option exercise price
$6.82 per share
Strike price for exercised Travere stock option
Shares held after sale
37,500 shares
Total Travere common shares owned directly post-transaction
Option expiration date
May 8, 2034
Expiration for the exercised 9,750-share stock option
Key Terms
Rule 10b5-1(c), open-market sale, stock option, derivative security, +1 more
5 terms
Rule 10b5-1(c) regulatory
"written plan adopted on November 17, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act"
Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
stock option financial
"The stock option is fully vested and exercisable."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
fully vested and exercisable financial
"The stock option is fully vested and exercisable."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Travere Therapeutics (TVTX) director Roy D. Baynes report on this Form 4?
Director Roy D. Baynes reported exercising stock options for 9,750 Travere shares at $6.82 and selling 9,750 shares at $44.22. The filing shows an exercise-and-sell sequence rather than a pure open-market purchase or sale of existing holdings.
What stock options did Roy D. Baynes exercise in Travere Therapeutics (TVTX)?
He exercised stock options covering 9,750 Travere common shares at a $6.82 exercise price. The options were fully vested and exercisable, and the filing links this option exercise directly to the 9,750 common shares later sold in the open market.
What is the expiration date of the Travere Therapeutics (TVTX) stock option exercised by Roy D. Baynes?
The exercised stock option, covering 9,750 Travere common shares at a $6.82 exercise price, has an expiration date of May 8, 2034. The Form 4 notes that this option was fully vested and exercisable at the time of the reported transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
